|
|
||||||||||
Clinical Pharmacist, Department of Pharmacy and Drug Information, Grady Health System, Atlanta, GA
Drug Information Specialist; Clinical Assistant Professor, Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL
Clinical CoordinatorDrug Information, New York Presbyterian Hospital, New York, NY
Reprints: Dr. Patka, Department of Pharmacy and Drug Information, Grady Health System, 80 Jessie Hill Jr. Dr., SE, Atlanta, GA 30303-3031, fax 404/616-2227, jpatka{at}gmh.edu
OBJECTIVE: To compare the use of high- and low-dose oxytocin for augmentation or induction of labor.
DATA SOURCES: Clinical trials were accessed through MEDLINE (1966-November 2003). Published literature relevant to the use of oxytocin for augmentation or induction of labor was evaluated.
STUDY SELECTION AND DATA EXTRACTION: Articles identified from the data sources were evaluated and included if they were clinical trials comparing high-versus low-dose oxytocin for augmentation or induction of labor.
DATA SYNTHESIS: Oxytocin is a treatment of choice for augmentation and induction of labor; however, no consensus exists regarding optimal dosing. Relevant studies comparing high-dose (2-6 mU/min) and low-dose (1-2 mU/min) therapy for labor augmentation and induction were evaluated.
CONCLUSIONS: High-dose oxytocin decreases the time from admission to vaginal delivery, but does not appear to decrease the incidence of cesarean sections when compared with low-dose therapy.
Key Words: augmentation, induction, labor, oxytocin
Published Online, November 30, 2004. www.theannals.com, DOI 10.1345/aph.1E037
THIS ARTICLE IS APPROVED FOR CONTINUING EDUCATION CREDIT
ACPE UNIVERSAL PROGRAM NUMBER: 407-000-05-004-H01